← Back to headlines
Quantum BioPharma to Voluntarily Delist Class B Shares
The biotechnology firm announced plans to remove its Class B shares from the Canadian Securities Exchange, streamlining its listing structure.
1 Sept, 23:00 — 1 Sept, 23:00
The biotechnology firm announced plans to remove its Class B shares from the Canadian Securities Exchange, streamlining its listing structure.